Spleen Tyrosine Kinase Is Overexpressed and Represents a Potential Therapeutic Target in Chronic Lymphocytic Leukemia
2009 · Cancer Research · 177 citations
https://doi.org/10.1158/0008-5472.can-08-4252
M
Maike Buchner
TUM Klinikum(DE)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
73
Papers
2.2K
Citations
21
h-index
28
i10-index
Maike Buchner is an academic researcher from TUM Klinikum. The author has contributed to research in topics: Chronic Lymphocytic Leukemia Research & Acute Lymphoblastic Leukemia research & PI3K/AKT/mTOR signaling in cancer. The author has an h-index of 21, co-authored 63 publications.
ORCID: 0000-0002-4196-096XPapers by this author
worksSignalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia
2015 · Nature · 152 citations
https://doi.org/10.1038/nature14231
Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia
2015 · Cancer Cell · 133 citations
https://doi.org/10.1016/j.ccell.2015.05.008
PTEN opposes negative selection and enables oncogenic transformation of pre-B cells
2016 · Nature Medicine · 119 citations
https://doi.org/10.1038/nm.4062
Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia
2021 · Nature Communications · 80 citations
https://doi.org/10.1038/s41467-021-23752-2
Identification of FOXM1 as a therapeutic target in B-cell lineage acute lymphoblastic leukaemia
2015 · Nature Communications · 49 citations
https://doi.org/10.1038/ncomms7471
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat